Eli Lilly & Co. (LLY) Tops Q4 EPS by 3c; Boosts FY13 EPS Outlook
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $0.85, $0.03 better ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
